Koh E - Search Results

1

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism.

Koh E, Hwang IY, Lee HL, De Sotto R, Lee JWJ, Lee YS, March JC, Chang MW. Koh E, et al. Nat Commun. 2022 Jul 4;13(1):3834. doi: 10.1038/s41467-022-31334-z. Nat Commun. 2022. PMID: 35787625 Free PMC article.

2

Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models.

Hwang IY, Koh E, Wong A, March JC, Bentley WE, Lee YS, Chang MW. Hwang IY, et al. Among authors: koh e. Nat Commun. 2017 Apr 11;8:15028. doi: 10.1038/ncomms15028. Nat Commun. 2017. PMID: 28398304 Free PMC article.

3

Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.

Hwang IY, Koh E, Kim HR, Yew WS, Chang MW. Hwang IY, et al. Among authors: koh e. Drug Resist Updat. 2016 Jul;27:59-71. doi: 10.1016/j.drup.2016.06.002. Epub 2016 Jun 22. Drug Resist Updat. 2016. PMID: 27449598 Review.

4

Reprogramming microbes to be pathogen-seeking killers.

Hwang IY, Tan MH, Koh E, Ho CL, Poh CL, Chang MW. Hwang IY, et al. Among authors: koh e. ACS Synth Biol. 2014 Apr 18;3(4):228-37. doi: 10.1021/sb400077j. Epub 2013 Sep 13. ACS Synth Biol. 2014. PMID: 24020906

5

Biotherapeutic Approaches in Atopic Dermatitis.

Tham EH, Koh E, Common JEA, Hwang IY. Tham EH, et al. Among authors: koh e. Biotechnol J. 2020 Oct;15(10):e1900322. doi: 10.1002/biot.201900322. Epub 2020 Apr 6. Biotechnol J. 2020. PMID: 32176834 Review.

6

Mediator acts upstream of the transcriptional activator Gal4.

Ang K, Ee G, Ang E, Koh E, Siew WL, Chan YM, Nur S, Tan YS, Lehming N. Ang K, et al. Among authors: koh e. PLoS Biol. 2012;10(3):e1001290. doi: 10.1371/journal.pbio.1001290. Epub 2012 Mar 27. PLoS Biol. 2012. PMID: 22479149 Free PMC article.

7

Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data.

Yoo SK, Fitzgerald CW, Cho BA, Fitzgerald BG, Han C, Koh ES, Pandey A, Sfreddo H, Crowley F, Korostin MR, Debnath N, Leyfman Y, Valero C, Lee M, Vos JL, Lee AS, Zhao K, Lam S, Olumuyide E, Kuo F, Wilson EA, Hamon P, Hennequin C, Saffern M, Vuong L, Hakimi AA, Brown B, Merad M, Gnjatic S, Bhardwaj N, Galsky MD, Schadt EE, Samstein RM, Marron TU, Gönen M, Morris LGT, Chowell D. Yoo SK, et al. Among authors: koh es. Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03398-5. Online ahead of print. Nat Med. 2025. PMID: 39762425

8

Mesenchymal Stem Cells Mediated Suppression of GREM2 Inhibits Renal Epithelial-Mesenchymal Transition and Attenuates the Progression of Diabetic Kidney Disease.

Ko MS, Yun JY, Kim S, Kim MO, Go SH, Jin HJ, Koh EH. Ko MS, et al. Among authors: koh eh. Int J Stem Cells. 2025 Jan 6. doi: 10.15283/ijsc24113. Online ahead of print. Int J Stem Cells. 2025. PMID: 39757007 Free article.

9

An Investigation of Adolescent Mental Health In a New York City Cohort Before and During the COVID-19 Pandemic in the Primary Care Setting.

Hano D, An A, Nghiem J, Koh E, Tripathi V, Wirtshafter R, Green C. Hano D, et al. Among authors: koh e. Matern Child Health J. 2025 Jan 3. doi: 10.1007/s10995-024-04037-8. Online ahead of print. Matern Child Health J. 2025. PMID: 39751723

10

Haptoglobin 2-2 genotype is associated with increased risk of cardiovascular disease in patients with rheumatoid arthritis: a matched case-control study.

Xu C, Khin LW, Tam HZ, Goh LL, Koh ET, Dalan R, Leong KP. Xu C, et al. Among authors: koh et. Front Med (Lausanne). 2024 Dec 17;11:1442858. doi: 10.3389/fmed.2024.1442858. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39741512 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,425 results

Search Page

Filters